why choose us

First received: September 22, 2022

Clinical Trial: Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma

Study Status: Completed

Recruit Status: RECRUITING

Condition: High-grade Glioma

Study Type: INTERVENTIONAL


Official Title: A Phase 1b Open-Label Study Investigating the Tolerability, Safety, and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma

Brief Summary: This is a phase 1 open-label, multicenter study to investigate tolerability, safety and PK properties of oral OKN-007 in patients with recurrent high-grade glioma.

Read more